
Avenue Therapeutics ATXI
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Avenue Therapeutics P/B 2011-2026 | ATXI
P/B Jährlich Avenue Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.293 | 0.0345 | 0.703 | 0.112 | 41.5 | 21.9 | -101 | 1.32 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.5 | -101 | -4.39 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
8.07 | $ 2.11 | -13.17 % | $ 217 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Apellis Pharmaceuticals
APLS
|
7.49 | $ 20.52 | -2.12 % | $ 2.59 B | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Axsome Therapeutics
AXSM
|
98.2 | $ 164.13 | 0.15 % | $ 8.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.49 | -3.11 % | $ 15.6 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
BridgeBio Pharma
BBIO
|
-6.31 | $ 64.24 | -3.37 % | $ 12.3 B | ||
|
BioAtla
BCAB
|
2.03 | $ 0.18 | -26.92 % | $ 8.6 M | ||
|
BioCardia
BCDA
|
-5.55 | $ 1.37 | 6.2 % | $ 29 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
-3.61 | $ 8.61 | -1.66 % | $ 1.78 B | ||
|
Black Diamond Therapeutics
BDTX
|
1.25 | $ 2.4 | -3.04 % | $ 132 M | ||
|
Beam Therapeutics
BEAM
|
2.58 | $ 28.29 | -0.6 % | $ 2.8 B | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.47 | -0.43 % | $ 742 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Biogen
BIIB
|
1.61 | $ 187.68 | -2.16 % | $ 27.5 B | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
0.128 | $ 1.38 | -0.01 % | $ 2.04 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
BioLineRx Ltd.
BLRX
|
19.9 | $ 2.91 | 2.83 % | $ 908 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.92 | $ 60.68 | -1.7 % | $ 11.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
6.61 | $ 62.54 | 0.27 % | $ 127 B | ||
|
Benitec Biopharma
BNTC
|
5.72 | $ 10.85 | -0.5 % | $ 447 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 109.85 | -0.34 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
BioXcel Therapeutics
BTAI
|
-0.0577 | $ 1.63 | -2.69 % | $ 4.13 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 8.6 | 1.9 % | $ 1.39 B | ||
|
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M |